Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bakris

Showing results (171-180 of 991) with videos related to

Pageof 100
Sort By:
Kidney International|March 15, 2008
Calcium antagonists: Do they equally protect against kidney injury?P Hart, G L Bakris
Current Opinion in Nephrology and Hypertension|October 19, 2016
Mineralocorticoid antagonists in chronic kidney diseaseOmar Al Dhaybi, George Bakris
Postgraduate Medicine|November 1, 1981
Psychogenic vertigo: a reviewS Tiwari, G L Bakris
American Journal of Hypertension|April 21, 2020
How to Manage Hypertension in People With DiabetesWaleed Ali, George L Bakris
Clinical Journal of the American Society of Nephrology : CJASN|April 17, 2024
Did the SCORED Trial Get Extra Points for Kidney Outcomes? If So, It Is Not ObviousNupur Mistry, George L Bakris
Journal of Hypertension|June 25, 2010
More complete renin-angiotensin system blockade: better outcomes or smoke and mirrorsGeorge L Bakris, Anil Bidani
Journal of Cardiovascular Risk|August 1, 1997
Renal components of the hypertensive syndromeN Tarif, G L Bakris
Nature Reviews. Nephrology|July 19, 2016
Diabetic nephropathy: SGLT2 inhibitors might halt progression of diabetic nephropathyHala Yamout, George L Bakris
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 12, 1997
Preservation of renal function: the spectrum of effects by calcium-channel blockersN Tarif, G L Bakris
Current Opinion in Nephrology and Hypertension|June 29, 2011
Newer renin-angiotensin-aldosterone system blocker combinations: is there an advantage?Ivana Lazich, George L Bakris
Pageof 100

Showing results (171-180 of 991) with videos related to

Sort By:
Pageof 100
Kidney International|March 15, 2008
Calcium antagonists: Do they equally protect against kidney injury?P Hart, G L Bakris
Current Opinion in Nephrology and Hypertension|October 19, 2016
Mineralocorticoid antagonists in chronic kidney diseaseOmar Al Dhaybi, George Bakris
Postgraduate Medicine|November 1, 1981
Psychogenic vertigo: a reviewS Tiwari, G L Bakris
American Journal of Hypertension|April 21, 2020
How to Manage Hypertension in People With DiabetesWaleed Ali, George L Bakris
Clinical Journal of the American Society of Nephrology : CJASN|April 17, 2024
Did the SCORED Trial Get Extra Points for Kidney Outcomes? If So, It Is Not ObviousNupur Mistry, George L Bakris
Journal of Hypertension|June 25, 2010
More complete renin-angiotensin system blockade: better outcomes or smoke and mirrorsGeorge L Bakris, Anil Bidani
Journal of Cardiovascular Risk|August 1, 1997
Renal components of the hypertensive syndromeN Tarif, G L Bakris
Nature Reviews. Nephrology|July 19, 2016
Diabetic nephropathy: SGLT2 inhibitors might halt progression of diabetic nephropathyHala Yamout, George L Bakris
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 12, 1997
Preservation of renal function: the spectrum of effects by calcium-channel blockersN Tarif, G L Bakris
Current Opinion in Nephrology and Hypertension|June 29, 2011
Newer renin-angiotensin-aldosterone system blocker combinations: is there an advantage?Ivana Lazich, George L Bakris
Pageof 100